u/salma_almeida

Analytically this is a small-molecule identity and purity problem, not a peptide one. The methods, the impurity classes and the reference standards are all different.

Vendor source pages carry an outbound link to the supplier’s own storefront, marked nofollow and sponsored, disclosed on the page and again on the funding page. Nothing is received for it.

Not convinced. A purity figure without a stated method is not comparable to one that has a method attached.

Correcting my own post above — that was week 69, not the week I wrote. Same story, wrong number.

Careful — that reads as advice about what someone else should do, and this board is for describing your own.

This is the one I would put in the sidebar. The middle is where everyone lives.

What timeframe is that over?

Weighing under consistent conditions — same time, same state, same scale — removes most of the apparent variability people find distressing.

Rate of change is not a virtue.

line_demir is right that the clothes tell you before the scale does.

Withdrawal studies in this class consistently show substantial regain after discontinuation.

Disagreeing with this bit: a two-kilo range is not drift and treating it as a problem creates one.

Careful — purity methods for peptides do not read across to a small molecule and the numbers are not equivalent.

Yes — nothing containing this is approved anywhere, and the threads keep forgetting it.

Yes — interval stretching and dose reduction are different levers and people use the words interchangeably.

That is the controversial ordering, not the hot one. Different formula, different behaviour.